|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net loss | |||||
| Adjustments to reconcile net loss to net cash provided by (used in) operating activities: | |||||
| Depreciation and amortization | |||||
| Stock-based compensation | |||||
| Equity in (income) loss of unconsolidated entities | |||||
| Change in acquisition-related contingent consideration | |||||
| Bad debt expense | |||||
| Amortization of debt issuance costs | |||||
| Changes in operating assets and liabilities: | |||||
| Accounts receivable | |||||
| Compass Concierge receivables | |||||
| Other current assets | |||||
| Other non-current assets | |||||
| Operating lease right-of-use assets and operating lease liabilities | |||||
| Accounts payable | |||||
| Commissions payable | |||||
| Accrued expenses and other liabilities | |||||
| Net cash provided by (used in) operating activities | |||||
| Investing Activities | |||||
| Investment in unconsolidated entities | |||||
| Capital expenditures | |||||
| Payments for acquisitions, net of cash acquired | |||||
| Net cash used in investing activities | |||||
| Financing Activities | |||||
| Proceeds from exercise of stock options | |||||
| Proceeds from issuance of common stock under the Employee Stock Purchase Plan | |||||
| Taxes paid related to net share settlement of equity awards | |||||
| Total taxes paid related to net share settlement of equity awards | |||||
| Proceeds from drawdowns on credit facility | |||||
| Concierge credit facility | |||||
| Revolving credit facility | |||||
| Repayments of drawdowns on credit facility | |||||
| Concierge credit facility | |||||
| Revolving credit facility | |||||
| Payments of issuance costs related to Credit Facilities | |||||
| Proceeds from issuance of common stock in connection with the Strategic Transaction | |||||
| Payments related to acquisitions, including contingent consideration | |||||
| Proceeds from issuance of common stock upon initial public offering, net of offering costs | |||||
| Other | |||||
| Net cash used in financing activities | |||||
| Net (decrease) increase in cash and cash equivalents | |||||
| Cash and cash equivalents at beginning of period | |||||
| Cash and cash equivalents at end of period | |||||
| Supplemental disclosures of cash flow information: | |||||
| Cash paid for interest | |||||
| Supplemental non-cash information: | |||||
| Issuance of common stock for acquisitions | |||||
| Conversion of convertible preferred stock in connection with initial public offering | |||||
| Conversion of Series D convertible preferred stock | |||||
| Series D | |||||
Loading...